Pediatric Unit, IRCCS Azienda Ospedaliero-Univerisitaria di Bologna, 40138 Bologna, Italy.
Clinica Pediatrica, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Medicina (Kaunas). 2021 Jan 30;57(2):124. doi: 10.3390/medicina57020124.
Mast cell disorders comprise a wide spectrum of syndromes caused by mast cells' degranulation with acute or chronic clinical manifestations. In this review article we reviewed the latest findings in scientific papers about mast cell disorders with a particular focus on mast cell activation syndrome and mastocytosis in pediatric age. Patients with mast cell activation syndrome have a normal number of mast cells that are hyperreactive upon stimulation of various triggers. We tried to emphasize the diagnostic criteria, differential diagnosis, and therapeutic strategies. Another primary mast cell disorder is mastocytosis, a condition with a long-known disease, in which patients have an increased number of mast cells that accumulate in different regions of the body with different clinical evolution in pediatric age. Mast cell activation syndrome overlaps with different clinical entities. No consensus was found on biomarkers and no clearly resolutive treatment is available. Therefore, a more detailed knowledge of this syndrome is of fundamental importance for a correct diagnosis and effective therapy.
肥大细胞疾病包括一组广泛的综合征,由肥大细胞脱颗粒引起,具有急性或慢性临床表现。在这篇综述文章中,我们回顾了关于肥大细胞疾病的科学论文中的最新发现,特别关注儿童时期的肥大细胞活化综合征和肥大细胞瘤。肥大细胞活化综合征患者的肥大细胞数量正常,但在受到各种刺激时会过度反应。我们试图强调诊断标准、鉴别诊断和治疗策略。另一种主要的肥大细胞疾病是肥大细胞瘤,这是一种已知病史较长的疾病,患者体内的肥大细胞数量增加,这些细胞会在体内不同部位积聚,在儿童时期具有不同的临床演变。肥大细胞活化综合征与不同的临床实体重叠。目前尚未发现生物标志物方面的共识,也没有明确的治疗方法。因此,对这种综合征有更详细的了解对于正确诊断和有效治疗至关重要。